AAS
RVPH

Avantax Advisory Services’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Avantax Advisory Services’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$21.9K Hold
2,875
– – ﹤0.01% 2341
2025
Q1 		$54.8K Sell
2,875
-125
-4% -$3.93K ﹤0.01% 2193
2024
Q4 		$109K Hold
3,000
– – ﹤0.01% 2117
2024
Q3 		$86.4K Buy
+3,000
New +$66.6K ﹤0.01% 2078

Other funds holding RVPH

DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Avantax Advisory Services's RVPH Position: Q2 2025 in Review

Avantax Advisory Services held its REVIVA PHARMA HLDGS INC (RVPH) position steady in Q2 2025 at 2,875 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

Avantax Advisory Services first reported a position in RVPH in Q3 2024 and has held it in 4 quarters since. The position peaked at $109K in Q4 2024. 46 funds tracked by Wall St. Rank hold RVPH as of Q2 2025.

  • Avantax Advisory Services held 2,875 shares of REVIVA PHARMA HLDGS INC worth $21.9K as of Q2 2025.
  • Avantax Advisory Services left its REVIVA PHARMA HLDGS INC share count unchanged in Q2 2025.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #2341 holding.
  • Avantax Advisory Services first reported a position in REVIVA PHARMA HLDGS INC in Q3 2024 and has held it in 4 quarters since.
  • Avantax Advisory Services's REVIVA PHARMA HLDGS INC position peaked at $109K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.